Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.

Kim D, Aizawa T, Wei H, Pi X, Rybalkin SD, Berk BC, Yan C.

J Mol Cell Cardiol. 2005 Jan;38(1):175-84. Epub 2004 Dec 8.

2.

Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.

Kim D, Rybalkin SD, Pi X, Wang Y, Zhang C, Munzel T, Beavo JA, Berk BC, Yan C.

Circulation. 2001 Nov 6;104(19):2338-43.

3.

cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.

Takimoto E, Champion HC, Belardi D, Moslehi J, Mongillo M, Mergia E, Montrose DC, Isoda T, Aufiero K, Zaccolo M, Dostmann WR, Smith CJ, Kass DA.

Circ Res. 2005 Jan 7;96(1):100-9. Epub 2004 Dec 2.

5.

Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.

Aizawa T, Wei H, Miano JM, Abe J, Berk BC, Yan C.

Circ Res. 2003 Sep 5;93(5):406-13. Epub 2003 Aug 14.

6.

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.

Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA.

Nat Med. 2005 Feb;11(2):214-22. Epub 2005 Jan 23.

PMID:
15665834
7.
9.

Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development.

Sanchez LS, de la Monte SM, Filippov G, Jones RC, Zapol WM, Bloch KD.

Pediatr Res. 1998 Feb;43(2):163-8.

PMID:
9475279
10.

ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.

Wyatt TA, Naftilan AJ, Francis SH, Corbin JD.

Am J Physiol. 1998 Feb;274(2 Pt 2):H448-55.

11.

Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.

Bruder-Nascimento T, Chinnasamy P, Riascos-Bernal DF, Cau SB, Callera GE, Touyz RM, Tostes RC, Sibinga NE.

J Mol Cell Cardiol. 2014 Jan;66:18-26.

12.

Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages.

Witwicka H, Kobiałka M, Siednienko J, Mitkiewicz M, Gorczyca WA.

Biochim Biophys Acta. 2007 Feb;1773(2):209-18. Epub 2006 Oct 24.

13.

Kinin B1 receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: receptors and mechanisms.

Morand-Contant M, Anand-Srivastava MB, Couture R.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1625-32. doi: 10.1152/ajpheart.00735.2009. Epub 2010 Sep 10.

14.
16.

Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.

Kai H, Fukui T, Lassègue B, Shah A, Minieri CA, Griendling KK.

Mol Pharmacol. 1996 Jan;49(1):96-104.

PMID:
8569718
17.

Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats.

Kim HY, Kang YJ, Song IH, Choi HC, Kim HS.

Hypertens Res. 2008 Mar;31(3):515-23. doi: 10.1291/hypres.31.515.

PMID:
18497472
18.

Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases.

Kotera J, Fujishige K, Imai Y, Kawai E, Michibata H, Akatsuka H, Yanaka N, Omori K.

Eur J Biochem. 1999 Jun;262(3):866-73.

20.
Items per page

Supplemental Content

Write to the Help Desk